16 12, 2020 Hope of a cure for cholangiocarcinoma coming from FGFR inhibitors Diatech Pharmacogenetics2021-01-12T14:36:11+01:00 Read More
28 09, 2020 Alpelisib and PIK3CA mutations: a new molecular targeted therapy for breast cancer is approved Diatech Pharmacogenetics2020-10-01T10:04:40+02:00 Read More
29 06, 2020 New European recommendations on DPD testing prior to anticancer therapy with fluoropyrimidines Diatech Pharmacogenetics2020-06-29T18:36:18+02:00 Read More
16 04, 2020 A new therapeutic opportunity treatment of NSCLC: the BRAF V600 mutation Diatech Pharmacogenetics2020-04-17T16:39:14+02:00 Read More
